XML 79 R30.htm IDEA: XBRL DOCUMENT v3.26.1
Stockholders' Equity (Tables)
9 Months Ended
Mar. 31, 2026
Stockholders' Equity  
Schedule of stock-based compensation expense in the consolidated statements of operations

We recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):

Three Months Ended March 31, 

  ​ ​ ​

Nine Months Ended March 31, 

  ​ ​ ​

2025

  ​ ​ ​

2026

2025

  ​ ​ ​

2026

Cost of goods sold

$

258

$

298

$

728

$

874

Selling, general and administrative

7,132

6,119

21,298

18,468

Research and development

173

168

468

493

Stock-based compensation expense

$

7,563

$

6,585

$

22,494

$

19,835

Schedule of stock option activity

Weighted

Average

Weighted-Average

Aggregate

Number of

Exercise

Remaining Contractual

Intrinsic Value

  ​ ​ ​

Options

  ​ ​ ​

Price

  ​ ​ ​

Term

  ​ ​ ​

(in thousands)

Outstanding at June 30, 2025

 

60,253

 

$

121.41

 

Granted

 

8,379

266.17

Exercised

 

(15,612)

109.36

Expired or forfeited

 

(618)

$

152.22

Outstanding at March 31, 2026

 

52,402

$

147.78

7.7 years

$

6,175

Exercisable at March 31, 2026

26,707

$

108.01

 

6.7 years

$

4,206

Summary of RSU award activity

Weighted-

Average

  ​ ​ ​

Shares

  ​ ​ ​

Fair Value

Nonvested at June 30, 2025

 

355,396

$

116.34

Granted

 

228,513

226.56

Vested

 

(338,715)

162.21

Forfeited

 

(2,316)

120.49

Nonvested at March 31, 2026

 

242,878

$

156.03